🇺🇸 FDA
Pipeline program

VX-433

VX25-433-001

Phase 1 small_molecule active

Quick answer

VX-433 for Narcolepsy Type 1 (NT1) is a Phase 1 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).

Program details

Company
VERTEX PHARMACEUTICALS INC / MA
Indication
Narcolepsy Type 1 (NT1)
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials